{"entity":{"type":"insider","cik":"0001880946","url":"/insider/0001880946","json_url":"/insider/0001880946.json","name":"Bensen Daniel","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":55,"n_filings":22,"first":"2023-03-23","last":"2026-02-13","span_basis":"filed_date"},"name_variants":[{"name":"Bensen Daniel","source":"filing","n_filings":22,"first_seen":"2023-03-23","last_seen":"2026-02-13"}],"transactions":[{"id":5943408,"accession":"0001193125-26-051534","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-051534","line_url":"/filing/0001193125-26-051534","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Discovery Officer)","role_mark":"O","role_mark_label":"Officer (Chief Discovery Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Discovery Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":32.8705632,"price_display":"32.87","price_state":"stated","total_value":262964.5056,"total_display":"262,964.51","total_whole":"262,965","shares_owned_after":146981.0,"shares_owned_after_display":"146,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-12","filed_date":"2026-02-13","scope":"insider","n_lines":2},{"id":5748730,"accession":"0001193125-26-016651","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-016651","line_url":"/filing/0001193125-26-016651","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Discovery Officer)","role_mark":"O","role_mark_label":"Officer (Chief Discovery Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Discovery Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":28.52320745,"price_display":"28.52","price_state":"stated","total_value":228185.6596,"total_display":"228,185.66","total_whole":"228,186","shares_owned_after":155998.0,"shares_owned_after_display":"155,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-20","scope":"insider","n_lines":2},{"id":5108560,"accession":"0001193125-25-320941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-320941","line_url":"/filing/0001193125-25-320941#line-1","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Discovery Officer)","role_mark":"O","role_mark_label":"Officer (Chief Discovery Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Discovery Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":22.6449,"price_display":"22.64","price_state":"stated","total_value":181159.2,"total_display":"181,159.20","total_whole":"181,159","shares_owned_after":162981.0,"shares_owned_after_display":"162,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-12","filed_date":"2025-12-16","scope":"insider"},{"id":4990888,"accession":"0001193125-25-288529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-288529","line_url":"/filing/0001193125-25-288529#line-2","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49956.0,"shares_display":"49,956","price_per_share":16.3203,"price_display":"16.32","price_state":"stated","total_value":815296.9068,"total_display":"815,296.91","total_whole":"815,297","shares_owned_after":170981.0,"shares_owned_after_display":"170,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-19","filed_date":"2025-11-19","scope":"insider"},{"id":4990885,"accession":"0001193125-25-288529","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-288529","line_url":"/filing/0001193125-25-288529#line-1","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75633.0,"shares_display":"75,633","price_per_share":16.0727,"price_display":"16.07","price_state":"stated","total_value":1215626.5191,"total_display":"1,215,626.52","total_whole":"1,215,627","shares_owned_after":220937.0,"shares_owned_after_display":"220,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-19","scope":"insider"},{"id":4298442,"accession":"0001193125-25-284935","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-284935","line_url":"/filing/0001193125-25-284935","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20072.0,"shares_display":"20,072","price_per_share":16.18165382622559,"price_display":"16.18","price_state":"stated","total_value":324798.1556,"total_display":"324,798.16","total_whole":"324,798","shares_owned_after":298070.0,"shares_owned_after_display":"298,070","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-17","scope":"insider","n_lines":2},{"id":4298434,"accession":"0001193125-25-284935","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-284935","line_url":"/filing/0001193125-25-284935#line-2","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110228.0,"shares_display":"110,228","price_per_share":16.0167,"price_display":"16.02","price_state":"stated","total_value":1765488.8076,"total_display":"1,765,488.81","total_whole":"1,765,489","shares_owned_after":316642.0,"shares_owned_after_display":"316,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-14","filed_date":"2025-11-17","scope":"insider"},{"id":4298428,"accession":"0001193125-25-284935","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-284935","line_url":"/filing/0001193125-25-284935#line-1","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1111.0,"shares_display":"1,111","price_per_share":16.0036,"price_display":"16.00","price_state":"stated","total_value":17779.9996,"total_display":"17,780.00","total_whole":"17,780","shares_owned_after":426870.0,"shares_owned_after_display":"426,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-17","scope":"insider"},{"id":2770770,"accession":"0000950170-24-071500","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-071500","line_url":"/filing/0000950170-24-071500#line-2","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3502.0,"shares_display":"3,502","price_per_share":20.0014,"price_display":"20.00","price_state":"stated","total_value":70044.9028,"total_display":"70,044.90","total_whole":"70,045","shares_owned_after":427981.0,"shares_owned_after_display":"427,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-10","filed_date":"2024-06-10","scope":"insider"},{"id":2770761,"accession":"0000950170-24-071500","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-071500","line_url":"/filing/0000950170-24-071500#line-1","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":4000.0,"total_display":"4,000.00","total_whole":"4,000","shares_owned_after":431483.0,"shares_owned_after_display":"431,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-07","filed_date":"2024-06-10","scope":"insider"},{"id":2735178,"accession":"0000950170-24-030932","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-030932","line_url":"/filing/0000950170-24-030932#line-1","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":4000.0,"total_display":"4,000.00","total_whole":"4,000","shares_owned_after":431683.0,"shares_owned_after_display":"431,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-13","scope":"insider"},{"id":2387294,"accession":"0000950170-24-028807","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-028807","line_url":"/filing/0000950170-24-028807#line-2","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68.0,"shares_display":"68","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":1360.0,"total_display":"1,360.00","total_whole":"1,360","shares_owned_after":431883.0,"shares_owned_after_display":"431,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-08","scope":"insider"},{"id":2387290,"accession":"0000950170-24-028807","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-028807","line_url":"/filing/0000950170-24-028807#line-1","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1733.0,"shares_display":"1,733","price_per_share":20.092,"price_display":"20.09","price_state":"stated","total_value":34819.436,"total_display":"34,819.44","total_whole":"34,819","shares_owned_after":431951.0,"shares_owned_after_display":"431,951","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-06","filed_date":"2024-03-08","scope":"insider"},{"id":3108831,"accession":"0000950170-24-026365","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-026365","line_url":"/filing/0000950170-24-026365#line-3","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1189.0,"shares_display":"1,189","price_per_share":20.0189,"price_display":"20.02","price_state":"stated","total_value":23802.4721,"total_display":"23,802.47","total_whole":"23,802","shares_owned_after":433684.0,"shares_owned_after_display":"433,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-05","scope":"insider"},{"id":3108828,"accession":"0000950170-24-026365","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-026365","line_url":"/filing/0000950170-24-026365#line-2","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5063.0,"shares_display":"5,063","price_per_share":20.0778,"price_display":"20.08","price_state":"stated","total_value":101653.9014,"total_display":"101,653.90","total_whole":"101,654","shares_owned_after":434873.0,"shares_owned_after_display":"434,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-05","scope":"insider"},{"id":3108825,"accession":"0000950170-24-026365","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-026365","line_url":"/filing/0000950170-24-026365#line-1","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2900.0,"shares_display":"2,900","price_per_share":20.0386,"price_display":"20.04","price_state":"stated","total_value":58111.94,"total_display":"58,111.94","total_whole":"58,112","shares_owned_after":439936.0,"shares_owned_after_display":"439,936","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider"},{"id":2458904,"accession":"0000950170-24-023406","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-023406","line_url":"/filing/0000950170-24-023406#line-3","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2050.0,"shares_display":"2,050","price_per_share":20.0016,"price_display":"20.00","price_state":"stated","total_value":41003.28,"total_display":"41,003.28","total_whole":"41,003","shares_owned_after":442836.0,"shares_owned_after_display":"442,836","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-02-29","scope":"insider"},{"id":2458901,"accession":"0000950170-24-023406","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-023406","line_url":"/filing/0000950170-24-023406#line-2","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5849.0,"shares_display":"5,849","price_per_share":20.128,"price_display":"20.13","price_state":"stated","total_value":117728.672,"total_display":"117,728.67","total_whole":"117,729","shares_owned_after":444886.0,"shares_owned_after_display":"444,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-02-29","scope":"insider"},{"id":2458897,"accession":"0000950170-24-023406","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-023406","line_url":"/filing/0000950170-24-023406#line-1","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":745.0,"shares_display":"745","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":14900.0,"total_display":"14,900.00","total_whole":"14,900","shares_owned_after":450735.0,"shares_owned_after_display":"450,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-27","filed_date":"2024-02-29","scope":"insider"},{"id":2175409,"accession":"0000950170-24-015559","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-015559","line_url":"/filing/0000950170-24-015559#line-1","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1501.0,"shares_display":"1,501","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":30020.0,"total_display":"30,020.00","total_whole":"30,020","shares_owned_after":451480.0,"shares_owned_after_display":"451,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-14","scope":"insider"},{"id":3252718,"accession":"0000950170-24-013474","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-013474","line_url":"/filing/0000950170-24-013474#line-1","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9587.0,"shares_display":"9,587","price_per_share":18.0939,"price_display":"18.09","price_state":"stated","total_value":173466.2193,"total_display":"173,466.22","total_whole":"173,466","shares_owned_after":452981.0,"shares_owned_after_display":"452,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-07","filed_date":"2024-02-09","scope":"insider"},{"id":2542726,"accession":"0000950170-24-011880","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-011880","line_url":"/filing/0000950170-24-011880#line-4","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15413.0,"shares_display":"15,413","price_per_share":18.0904,"price_display":"18.09","price_state":"stated","total_value":278827.3352,"total_display":"278,827.34","total_whole":"278,827","shares_owned_after":462568.0,"shares_owned_after_display":"462,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-06","scope":"insider"},{"id":2542722,"accession":"0000950170-24-011880","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-011880","line_url":"/filing/0000950170-24-011880","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75393.0,"shares_display":"75,393","price_per_share":16.32906521560357,"price_display":"16.33","price_state":"stated","total_value":1231097.2138,"total_display":"1,231,097.21","total_whole":"1,231,097","shares_owned_after":480281.0,"shares_owned_after_display":"480,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-06","scope":"insider","n_lines":2},{"id":8189098,"accession":"0001209191-23-043165","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-043165","line_url":"/filing/0001209191-23-043165#line-4","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":16.0071,"price_display":"16.01","price_state":"stated","total_value":62427.69,"total_display":"62,427.69","total_whole":"62,428","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-21","filed_date":"2023-07-21","scope":"insider"},{"id":8189090,"accession":"0001209191-23-043165","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-043165","line_url":"/filing/0001209191-23-043165#line-2","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":207.0,"shares_display":"207","price_per_share":16.075,"price_display":"16.08","price_state":"stated","total_value":3327.525,"total_display":"3,327.52","total_whole":"3,328","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-19","filed_date":"2023-07-21","scope":"insider"},{"id":8022945,"accession":"0001209191-23-042495","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-042495","line_url":"/filing/0001209191-23-042495#line-4","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":16.0337,"price_display":"16.03","price_state":"stated","total_value":30464.03,"total_display":"30,464.03","total_whole":"30,464","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-17","scope":"insider"},{"id":8022940,"accession":"0001209191-23-042495","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-042495","line_url":"/filing/0001209191-23-042495#line-2","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":16.13,"price_display":"16.13","price_state":"stated","total_value":8065.0,"total_display":"8,065.00","total_whole":"8,065","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-13","filed_date":"2023-07-17","scope":"insider"},{"id":7815893,"accession":"0001209191-23-042114","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-042114","line_url":"/filing/0001209191-23-042114#line-6","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":201.0,"shares_display":"201","price_per_share":16.2304,"price_display":"16.23","price_state":"stated","total_value":3262.3104,"total_display":"3,262.31","total_whole":"3,262","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-12","filed_date":"2023-07-12","scope":"insider"},{"id":7815888,"accession":"0001209191-23-042114","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-042114","line_url":"/filing/0001209191-23-042114#line-4","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":16.019,"price_display":"16.02","price_state":"stated","total_value":8009.5,"total_display":"8,009.50","total_whole":"8,010","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-11","filed_date":"2023-07-12","scope":"insider"},{"id":7815883,"accession":"0001209191-23-042114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-042114","line_url":"/filing/0001209191-23-042114#line-2","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1202.0,"shares_display":"1,202","price_per_share":16.0069,"price_display":"16.01","price_state":"stated","total_value":19240.2938,"total_display":"19,240.29","total_whole":"19,240","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-10","filed_date":"2023-07-12","scope":"insider"},{"id":8608088,"accession":"0001209191-23-040654","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-23-040654","line_url":"/filing/0001209191-23-040654","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4265.0,"shares_display":"4,265","price_per_share":16.369023798358732,"price_display":"16.37","price_state":"stated","total_value":69813.8865,"total_display":"69,813.89","total_whole":"69,814","shares_owned_after":528381.0,"shares_owned_after_display":"528,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-03","scope":"insider","n_lines":2},{"id":8608081,"accession":"0001209191-23-040654","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-040654","line_url":"/filing/0001209191-23-040654#line-4","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18819.0,"shares_display":"18,819","price_per_share":16.9732,"price_display":"16.97","price_state":"stated","total_value":319418.6508,"total_display":"319,418.65","total_whole":"319,419","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-30","filed_date":"2023-07-03","scope":"insider"},{"id":8608076,"accession":"0001209191-23-040654","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-040654","line_url":"/filing/0001209191-23-040654#line-2","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17281.0,"shares_display":"17,281","price_per_share":16.4929,"price_display":"16.49","price_state":"stated","total_value":285013.8049,"total_display":"285,013.80","total_whole":"285,014","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-29","filed_date":"2023-07-03","scope":"insider"},{"id":8254373,"accession":"0001209191-23-040105","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-23-040105","line_url":"/filing/0001209191-23-040105#line-8","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13524.0,"shares_display":"13,524","price_per_share":16.906,"price_display":"16.91","price_state":"stated","total_value":228636.744,"total_display":"228,636.74","total_whole":"228,637","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-28","filed_date":"2023-06-28","scope":"insider"},{"id":8254368,"accession":"0001209191-23-040105","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-040105","line_url":"/filing/0001209191-23-040105","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16028.0,"shares_display":"16,028","price_per_share":16.91256547916147,"price_display":"16.91","price_state":"stated","total_value":271074.5995,"total_display":"271,074.60","total_whole":"271,075","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-27","filed_date":"2023-06-28","scope":"insider","n_lines":2},{"id":8254362,"accession":"0001209191-23-040105","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-040105","line_url":"/filing/0001209191-23-040105","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17232.0,"shares_display":"17,232","price_per_share":16.766775719591458,"price_display":"16.77","price_state":"stated","total_value":288925.0792,"total_display":"288,925.08","total_whole":"288,925","shares_owned_after":534351.0,"shares_owned_after_display":"534,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-26","filed_date":"2023-06-28","scope":"insider","n_lines":2},{"id":8154441,"accession":"0001209191-23-037611","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-037611","line_url":"/filing/0001209191-23-037611#line-6","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12592.0,"shares_display":"12,592","price_per_share":16.1453,"price_display":"16.15","price_state":"stated","total_value":203301.6176,"total_display":"203,301.62","total_whole":"203,302","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-15","scope":"insider"},{"id":8154435,"accession":"0001209191-23-037611","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-037611","line_url":"/filing/0001209191-23-037611#line-4","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120.0,"shares_display":"120","price_per_share":16.45,"price_display":"16.45","price_state":"stated","total_value":1974.0,"total_display":"1,974.00","total_whole":"1,974","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-15","scope":"insider"},{"id":8154427,"accession":"0001209191-23-037611","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-037611","line_url":"/filing/0001209191-23-037611#line-2","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5628.0,"shares_display":"5,628","price_per_share":16.0144,"price_display":"16.01","price_state":"stated","total_value":90129.0432,"total_display":"90,129.04","total_whole":"90,129","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-15","scope":"insider"},{"id":8575251,"accession":"0001209191-23-022432","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-022432","line_url":"/filing/0001209191-23-022432#line-6","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":16.1569,"price_display":"16.16","price_state":"stated","total_value":32313.8,"total_display":"32,313.80","total_whole":"32,314","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-03","scope":"insider"},{"id":8575243,"accession":"0001209191-23-022432","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-022432","line_url":"/filing/0001209191-23-022432#line-4","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":16.0006,"price_display":"16.00","price_state":"stated","total_value":6400.24,"total_display":"6,400.24","total_whole":"6,400","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-31","filed_date":"2023-04-03","scope":"insider"},{"id":8575236,"accession":"0001209191-23-022432","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-022432","line_url":"/filing/0001209191-23-022432#line-2","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":16.0075,"price_display":"16.01","price_state":"stated","total_value":32015.0,"total_display":"32,015.00","total_whole":"32,015","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-30","filed_date":"2023-04-03","scope":"insider"},{"id":7994936,"accession":"0001209191-23-021564","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-021564","line_url":"/filing/0001209191-23-021564#line-6","is_derivative":false,"issuer_cik":"0001863127","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001863127","owner_cik":"0001880946","owner_name":"Bensen Daniel","owner_display_name":"Bensen Daniel","owner_url":"/insider/0001880946","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2187.0,"shares_display":"2,187","price_per_share":16.2134,"price_display":"16.21","price_state":"stated","total_value":35458.7058,"total_display":"35,458.71","total_whole":"35,459","shares_owned_after":527981.0,"shares_owned_after_display":"527,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-29","filed_date":"2023-03-29","scope":"insider"}],"collapsed":true,"next_cursor":"2023-03-29|7994936","ledger_fault":false,"count":{"value":55,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":55,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":55},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001863127","name":"Tyra Biosciences, Inc.","url":"/issuer/0001863127","role":"Officer (Chief Discovery Officer)","n_filings":22,"first_seen":"2023-03-23","last_seen":"2026-02-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001880946","retrieved_at":"2026-08-24T12:12:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}